Activating Compound | Comment | Organism | Structure |
---|---|---|---|
heparin | porcine intestinal heparin, increases activity by decreasing the Km value, increases the enzyme's thermostability | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
recombinant expression of the enzyme in Escherichia coli strain BL21(DE3) in inclusion bodies | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Cholesterol sulfate | non-competitive inhibition, decreases the enzyme's thermostability, inhibition mechanism, overview | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.019 | - |
(7-methoxycoumarin-4-yl)-acetyl-L-Pro-L-Leu-Gly-L-Leu-[N3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl]-L-Ala-L-Arg-NH2 | pH 7.5, 25°C, with 0.05 mM heparin | Homo sapiens | |
0.057 | - |
(7-methoxycoumarin-4-yl)-acetyl-L-Pro-L-Leu-Gly-L-Leu-[N3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl]-L-Ala-L-Arg-NH2 | pH 7.5, 25°C, without heparin | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P09237 | - |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
proteolytic modification | the enzyme is matured by proteolytic cleavage, the mature MMP-7 comprises Tyr78-Lys250 | Homo sapiens |
Purification (Comment) | Organism |
---|---|
recombinant solubilized and refolded enzyme from Escherichia coli strain BL21(DE3) inclusion bodies by ammonium sulfate fractionation and heparin affinity chromatography | Homo sapiens |
Renatured (Comment) | Organism |
---|---|
recombinant enzyme, solubilization from Escherichia coli strain BL21(DE3) inclusion bodies by 6 M guanidine HCl, and refolded with 1 M L-arginine | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(7-methoxycoumarin-4-yl)-acetyl-L-Pro-L-Leu-Gly-L-Leu-[N3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl]-L-Ala-L-Arg-NH2 + H2O | - |
Homo sapiens | (7-methoxycoumarin-4-yl)-acetyl-L-Pro-L-Leu-Gly + L-Leu-[N3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl]-L-Ala-L-Arg-NH2 | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Matrix metalloproteinase 7 | - |
Homo sapiens |
MMP-7 | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
25 | - |
assay at | Homo sapiens |
Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|
additional information | - |
in thermal incubation of the enzyme at 50-70°C, heparin increases the relative activity (the ratio of kcat/Km of MMP-7 with incubation to that without it), while cholesterol sulfate decreases the relative activity | Homo sapiens |
50 | 60 | purified enzyme with or without heparin and cholesterol sulfate, 10 min, 10-40% activity remaining, overview | Homo sapiens |
70 | - |
purified enzyme, inactivation within 10 min | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.5 | - |
assay at | Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.011 | - |
Cholesterol sulfate | pH 7.5, 25°C | Homo sapiens |